Prostate Cancer Clinical Trials in Cleveland

Showing 181-189 of 189 trials

Prophylactic Urethral Stenting With Memokath After Prostate Implantation for Prostate Adenocarcinoma

NCT00252941

The purpose of this study is to determine the feasibility, safety, and efficacy of the Memokath® 028SW stent to prevent urinary obstructive symptoms (difficulty urinating) when used after prostate seed implantation for the treatment of localized prostate cancer.

Prostate CancerPost-Brachytherapy Bladder Outlet Obstruction

The Cleveland Clinic20 participantsStarted Nov 2005

Cleveland, Ohio, United States

UNKNOWNPHASE2/PHASE3< 1 mile

ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere

NCT00043576

The purposes of this study are to determine if DN-101 plus Taxotere lowers PSA levels, delays or limits disease progression and is safe with minimal side effects.

Prostate Cancer

Novacea250 participantsStarted Aug 2002

Montgomery, Alabama, United States • Scottsdale, Arizona, United States • Tucson, Arizona, United States +59 more locations

Prophylactic Urethral Stenting With Memokath After Prostate Implantation for Prostate Adenocarcinoma

ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere

Prostate Cancer Trials in Other Cities

Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer

Docetaxel in Combination With GVAX ® Immunotherapy Versus Docetaxel and Prednisone in Prostate Cancer Patients

Study of Abarelix in Androgen-Independent Prostate Cancer Progressing After Agonist Therapy

A Comparative Study of Degarelix Three-month Depot in Three Different Dosing Regimens in Patients With Prostate Cancer

Leuprolide Acetate 3.75 mg Depot to Treat Prostate Cancer

A Phase I Dose-Escalation Study of BMS-641988 in Patients With Castration-Resistant Prostate Cancer

Safety of LBH589 Alone and in Combination With Intravenous Docetaxel and Prednisone

Other Conditions in Cleveland